Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.01B | 5.10B | 3.47B | 3.29B | 2.91B | Gross Profit |
1.01B | 584.70M | 3.47B | 3.29B | 2.91B | EBIT |
1.42B | 1.29B | 584.00M | 408.10M | -10.20M | EBITDA |
1.42B | -374.60M | 613.90M | 409.60M | 0.00 | Net Income Common Stockholders |
1.13B | 1.03B | 483.30M | 308.70M | -46.10M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
882.10M | 593.30M | 652.50M | 591.80M | 309.50M | Total Assets |
15.42B | 13.67B | 15.10B | 12.81B | 10.59B | Total Debt |
615.60M | 624.90M | 620.70M | 631.90M | 637.20M | Net Debt |
-266.50M | -187.40M | -31.80M | 40.10M | 327.70M | Total Liabilities |
10.81B | 9.78B | 12.53B | 10.68B | 8.78B | Stockholders Equity |
4.61B | 3.88B | 2.57B | 2.13B | 1.81B |
Cash Flow | Free Cash Flow | |||
572.10M | 338.00M | 1.10B | 1.17B | 463.90M | Operating Cash Flow |
634.90M | 393.20M | 1.10B | 1.17B | 476.80M | Investing Cash Flow |
-62.80M | -55.20M | -1.25B | -839.20M | -611.90M | Financing Cash Flow |
-515.60M | -190.80M | 235.70M | -48.00M | 177.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | £5.66B | 6.72 | 26.32% | 2.71% | 7.79% | 9.99% | |
79 Outperform | £10.11B | 15.24 | 56.17% | 8.61% | 34.86% | 95.18% | |
76 Outperform | £1.38B | 5.41 | 21.23% | 6.36% | 14.46% | -2.98% | |
65 Neutral | £342.50M | 9.46 | 14.37% | 4.96% | 32.88% | 99.17% | |
64 Neutral | $12.77B | 9.71 | 7.85% | 78.06% | 12.07% | -7.97% | |
63 Neutral | £3.87B | 26.55 | 5.97% | 3.35% | 26.11% | -29.43% | |
$5.84B | 9.44 | 17.96% | 3.46% | ― | ― |